+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intrathecal Pumps Market Size, Share & Industry Trends Analysis Report By Application (Pain, and Spasticity), By Type (Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 198 Pages
  • December 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5922416
The Global Intrathecal Pumps Market size is expected to reach $491.7 million by 2030, rising at a market growth of 5.7% CAGR during the forecast period.

Bupivacaine is regarded as an exceptional adjunctive drug in intrathecal therapy. Thus, the Bupivacaine segment acquired $36,149.5 thousand in 2022. The synergistic enhancement of intrathecal opioid effects when bupivacaine is combined with them has been demonstrated in multiple studies, which has contributed significantly to its expanding market share. Bupivacaine reduces dose escalations of intrathecal opioids and permits some patients to reduce their oral opioid utilization. Thus, it is envisaged that several benefits associated with bupivacaine will sustain segment expansion. Some of the factors impacting the market are technological advancements in pump design, expanding applications in pain management and neurological disorders, and high initial costs and economic considerations.

Modern intrathecal pumps have advanced mechanisms that enable precise and accurate drug delivery. This precision is crucial for administering the proper medication dosage directly to the spinal cord, optimizing therapeutic effects while minimizing the risk of side effects. The integration of smart pump technologies has enhanced the capabilities of intrathecal pumps. These technologies often include remote monitoring, connectivity, and data analytics features. Healthcare providers can remotely monitor patient data, receive real-time alerts, and adjust the pump settings, improving overall patient care and management. Additionally, intrathecal pumps were initially developed for pain management, but their successful application has expanded to address a variety of neurological disorders, including spasticity, dystonia, and severe cases of Parkinson's disease. This diversification broadens the potential patient population benefitting from intrathecal pump therapy. Using these pumps in neurological disorders improves functionality and mobility in affected individuals. By directly targeting the underlying neurological mechanisms, these pumps help reduce muscle spasticity, dystonia, and other symptoms that can enormously impact a person's ability to move and perform daily activities. Healthcare teams comprising pain specialists, neurologists, and other relevant specialists collaborate to develop comprehensive treatment plans that address pain and associated neurological symptoms. Thus, the above-mentioned factors will expand the market growth.

Further, the COVID-19 pandemic moderately impacted the market. Many elective surgeries and medical procedures, including those related to intrathecal pump implantation, were postponed, or canceled during the initial phases of the pandemic. Hospitals and healthcare facilities were under immense pressure to prioritize COVID-19 cases, leading to delays in non-urgent procedures. This delay had influenced the market's growth trajectory, as patients defer elective surgeries, affecting both new installations and replacements. The global disruptions in supply chains caused by the pandemic have affected the availability of medical devices and components. Manufacturers of these pumps and related accessories faced challenges in procuring raw materials, production delays, and logistical issues. These disruptions contributed to fluctuations in the market, affecting both the supply and demand sides. As a result, due to these changes, the market is expected to grow significantly in the coming years.

However, the substantial upfront costs associated with intrathecal pump therapy, including the cost of the pump, surgical implantation, and related procedures, can create financial barriers to access. Patients without adequate insurance coverage or financial resources may face challenges accessing this advanced treatment option. Inconsistent or inadequate reimbursement policies can hinder the widespread adoption of intrathecal pump therapy. The lack of reimbursement or reimbursement rates that do not adequately cover the costs associated with the therapy may discourage healthcare providers from offering it as a treatment option. The financial burden on patients could lead to decreased patient adherence, reluctance to pursue intrathecal pump therapy or potential treatment discontinuation. Due to the above aspects, market growth is expected to decline in the coming years.

Type Outlook

On the basis of type, the market is segmented into baclofen, bupivacaine, clonidine, morphine, ziconotide, and others. In 2022, the morphine segment dominated the market with the maximum revenue share. Morphine is the benchmark for intrathecal drug delivery due to its robust affinity for receptors, consistent performance, and substantial body of user knowledge. Furthermore, morphine has been granted sanction by the US FDA for the treatment of long-term intrathecal pain. Furthermore, compared to systemic opioids, long-term intrathecal morphine has fewer adverse effects, which is anticipated to stimulate the growth of this market segment. Owing to their ability to alleviate discomfort, opioids like morphine are frequently prescribed, per the WHO. They efficiently alleviate a wide range of pain, encompassing both acute and chronic ailments. Pain signals are diminished through the action of these medications on specific receptors in the brain and spinal cord.

"intrathecal-pumps-market-share.jpg" title="Intrathecal Pumps Market Share and Industry Analysis Report 2022"/>

Application Outlook

Based on application, the market is fragmented into spasticity and pain. The spasticity segment garnered a significant revenue share in the market in 2022. It delivers medications, such as baclofen, directly to the spinal cord. Baclofen is a muscle relaxant that operates on the central nervous system to reduce spasticity. The targeted delivery allows for a more adequate concentration of the drug at its site of action, leading to better control of muscle tone and spasticity. Controlling spasticity through intrathecal pump therapy can improve muscle function and range of motion. This allows individuals to engage in physical therapy and rehabilitation more effectively, improving overall mobility and functionality.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The presence of adequately equipped primary, secondary, and tertiary care facilities bolstered growth in the North American market. In addition, favorable government funding and a robust reimbursement network are anticipated to drive market expansion. Expected to stimulate demand for intrathecal pumps in this region are the increasing collaborative efforts of key market participants to enhance their product lines and guarantee superior quality. An increased demand for sophisticated and effective intrathecal pumps is a result of the escalating incidence of cancer in the United States.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic plc, ICU Medical, Inc. (Smiths Medical), Teleflex, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Baxter International, Inc., Abbott Laboratories, Tricumed Medizintechnik GmbH, Flowonix Medical, Inc., Durect Corporation, and Novartis AG

Scope of the Study

Market Segments Covered in the Report:


By Application

  • Pain
  • Spasticity

By Type

  • Morphine
  • Ziconotide
  • Baclofen
  • Bupivacaine
  • Clonidine
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic plc
  • ICU Medical, Inc. (Smiths Medical)
  • Teleflex, Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Baxter International, Inc.
  • Abbott Laboratories
  • Tricumed Medizintechnik GmbH
  • Flowonix Medical, Inc.
  • Durect Corporation
  • Novartis AG

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Intrathecal Pumps Market, by Application
1.4.2 Global Intrathecal Pumps Market, by Type
1.4.3 Global Intrathecal Pumps Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Global Intrathecal Pumps Market by Application
4.1 Global Pain Market by Region
4.2 Global Spasticity Market by Region
Chapter 5. Global Intrathecal Pumps Market by Type
5.1 Global Morphine Market by Region
5.2 Global Ziconotide Market by Region
5.3 Global Baclofen Market by Region
5.4 Global Bupivacaine Market by Region
5.5 Global Clonidine Market by Region
5.6 Global Others Market by Region
Chapter 6. Global Intrathecal Pumps Market by Region
6.1 North America Intrathecal Pumps Market
6.1.1 North America Intrathecal Pumps Market by Application
6.1.1.1 North America Pain Market by Region
6.1.1.2 North America Spasticity Market by Region
6.1.2 North America Intrathecal Pumps Market by Type
6.1.2.1 North America Morphine Market by Country
6.1.2.2 North America Ziconotide Market by Country
6.1.2.3 North America Baclofen Market by Country
6.1.2.4 North America Bupivacaine Market by Country
6.1.2.5 North America Clonidine Market by Country
6.1.2.6 North America Others Market by Country
6.1.3 North America Intrathecal Pumps Market by Country
6.1.3.1 US Intrathecal Pumps Market
6.1.3.1.1 US Intrathecal Pumps Market by Application
6.1.3.1.2 US Intrathecal Pumps Market by Type
6.1.3.2 Canada Intrathecal Pumps Market
6.1.3.2.1 Canada Intrathecal Pumps Market by Application
6.1.3.2.2 Canada Intrathecal Pumps Market by Type
6.1.3.3 Mexico Intrathecal Pumps Market
6.1.3.3.1 Mexico Intrathecal Pumps Market by Application
6.1.3.3.2 Mexico Intrathecal Pumps Market by Type
6.1.3.4 Rest of North America Intrathecal Pumps Market
6.1.3.4.1 Rest of North America Intrathecal Pumps Market by Application
6.1.3.4.2 Rest of North America Intrathecal Pumps Market by Type
6.2 Europe Intrathecal Pumps Market
6.2.1 Europe Intrathecal Pumps Market by Application
6.2.1.1 Europe Pain Market by Country
6.2.1.2 Europe Spasticity Market by Country
6.2.2 Europe Intrathecal Pumps Market by Type
6.2.2.1 Europe Morphine Market by Country
6.2.2.2 Europe Ziconotide Market by Country
6.2.2.3 Europe Baclofen Market by Country
6.2.2.4 Europe Bupivacaine Market by Country
6.2.2.5 Europe Clonidine Market by Country
6.2.2.6 Europe Others Market by Country
6.2.3 Europe Intrathecal Pumps Market by Country
6.2.3.1 Germany Intrathecal Pumps Market
6.2.3.1.1 Germany Intrathecal Pumps Market by Application
6.2.3.1.2 Germany Intrathecal Pumps Market by Type
6.2.3.2 UK Intrathecal Pumps Market
6.2.3.2.1 UK Intrathecal Pumps Market by Application
6.2.3.2.2 UK Intrathecal Pumps Market by Type
6.2.3.3 France Intrathecal Pumps Market
6.2.3.3.1 France Intrathecal Pumps Market by Application
6.2.3.3.2 France Intrathecal Pumps Market by Type
6.2.3.4 Russia Intrathecal Pumps Market
6.2.3.4.1 Russia Intrathecal Pumps Market by Application
6.2.3.4.2 Russia Intrathecal Pumps Market by Type
6.2.3.5 Spain Intrathecal Pumps Market
6.2.3.5.1 Spain Intrathecal Pumps Market by Application
6.2.3.5.2 Spain Intrathecal Pumps Market by Type
6.2.3.6 Italy Intrathecal Pumps Market
6.2.3.6.1 Italy Intrathecal Pumps Market by Application
6.2.3.6.2 Italy Intrathecal Pumps Market by Type
6.2.3.7 Rest of Europe Intrathecal Pumps Market
6.2.3.7.1 Rest of Europe Intrathecal Pumps Market by Application
6.2.3.7.2 Rest of Europe Intrathecal Pumps Market by Type
6.3 Asia Pacific Intrathecal Pumps Market
6.3.1 Asia Pacific Intrathecal Pumps Market by Application
6.3.1.1 Asia Pacific Pain Market by Country
6.3.1.2 Asia Pacific Spasticity Market by Country
6.3.2 Asia Pacific Intrathecal Pumps Market by Type
6.3.2.1 Asia Pacific Morphine Market by Country
6.3.2.2 Asia Pacific Ziconotide Market by Country
6.3.2.3 Asia Pacific Baclofen Market by Country
6.3.2.4 Asia Pacific Bupivacaine Market by Country
6.3.2.5 Asia Pacific Clonidine Market by Country
6.3.2.6 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Intrathecal Pumps Market by Country
6.3.3.1 China Intrathecal Pumps Market
6.3.3.1.1 China Intrathecal Pumps Market by Application
6.3.3.1.2 China Intrathecal Pumps Market by Type
6.3.3.2 Japan Intrathecal Pumps Market
6.3.3.2.1 Japan Intrathecal Pumps Market by Application
6.3.3.2.2 Japan Intrathecal Pumps Market by Type
6.3.3.3 India Intrathecal Pumps Market
6.3.3.3.1 India Intrathecal Pumps Market by Application
6.3.3.3.2 India Intrathecal Pumps Market by Type
6.3.3.4 South Korea Intrathecal Pumps Market
6.3.3.4.1 South Korea Intrathecal Pumps Market by Application
6.3.3.4.2 South Korea Intrathecal Pumps Market by Type
6.3.3.5 Singapore Intrathecal Pumps Market
6.3.3.5.1 Singapore Intrathecal Pumps Market by Application
6.3.3.5.2 Singapore Intrathecal Pumps Market by Type
6.3.3.6 Malaysia Intrathecal Pumps Market
6.3.3.6.1 Malaysia Intrathecal Pumps Market by Application
6.3.3.6.2 Malaysia Intrathecal Pumps Market by Type
6.3.3.7 Rest of Asia Pacific Intrathecal Pumps Market
6.3.3.7.1 Rest of Asia Pacific Intrathecal Pumps Market by Application
6.3.3.7.2 Rest of Asia Pacific Intrathecal Pumps Market by Type
6.4 LAMEA Intrathecal Pumps Market
6.4.1 LAMEA Intrathecal Pumps Market by Application
6.4.1.1 LAMEA Pain Market by Country
6.4.1.2 LAMEA Spasticity Market by Country
6.4.2 LAMEA Intrathecal Pumps Market by Type
6.4.2.1 LAMEA Morphine Market by Country
6.4.2.2 LAMEA Ziconotide Market by Country
6.4.2.3 LAMEA Baclofen Market by Country
6.4.2.4 LAMEA Bupivacaine Market by Country
6.4.2.5 LAMEA Clonidine Market by Country
6.4.2.6 LAMEA Others Market by Country
6.4.3 LAMEA Intrathecal Pumps Market by Country
6.4.3.1 Brazil Intrathecal Pumps Market
6.4.3.1.1 Brazil Intrathecal Pumps Market by Application
6.4.3.1.2 Brazil Intrathecal Pumps Market by Type
6.4.3.2 Argentina Intrathecal Pumps Market
6.4.3.2.1 Argentina Intrathecal Pumps Market by Application
6.4.3.2.2 Argentina Intrathecal Pumps Market by Type
6.4.3.3 UAE Intrathecal Pumps Market
6.4.3.3.1 UAE Intrathecal Pumps Market by Application
6.4.3.3.2 UAE Intrathecal Pumps Market by Type
6.4.3.4 Saudi Arabia Intrathecal Pumps Market
6.4.3.4.1 Saudi Arabia Intrathecal Pumps Market by Application
6.4.3.4.2 Saudi Arabia Intrathecal Pumps Market by Type
6.4.3.5 South Africa Intrathecal Pumps Market
6.4.3.5.1 South Africa Intrathecal Pumps Market by Application
6.4.3.5.2 South Africa Intrathecal Pumps Market by Type
6.4.3.6 Nigeria Intrathecal Pumps Market
6.4.3.6.1 Nigeria Intrathecal Pumps Market by Application
6.4.3.6.2 Nigeria Intrathecal Pumps Market by Type
6.4.3.7 Rest of LAMEA Intrathecal Pumps Market
6.4.3.7.1 Rest of LAMEA Intrathecal Pumps Market by Application
6.4.3.7.2 Rest of LAMEA Intrathecal Pumps Market by Type
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Trails and Approvals:
7.1.6 SWOT Analysis
7.2 ICU Medical, Inc. (Smiths Medical)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teleflex, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Baxter International, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Tricumed Medizintechnik GmbH
7.7.1 Company Overview
7.8 Flowonix Medical, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Trails and Approvals:
7.9 DURECT Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Chapter 8. Winning Imperatives of Intrathecal Pumps Market

Companies Mentioned

  • Medtronic plc
  • ICU Medical, Inc. (Smiths Medical)
  • Teleflex, Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Baxter International, Inc.
  • Abbott Laboratories
  • Tricumed Medizintechnik GmbH
  • Flowonix Medical, Inc.
  • Durect Corporation
  • Novartis AG

Methodology

Loading
LOADING...